Antigens, CD20
- Name
- Antigens, CD20
- Accession Number
- DBCAT000175
- Description
-
Not Available
- Drugs
-
Drug Drug Description Ibritumomab tiuxetan A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. Tositumomab A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. Ofatumumab An anti-CD20 antibody used for the treatment of chronic lymphocytic leukemia (CLL) in selected patients with certain treatment histories and responsiveness to anticancer medications. Obinutuzumab An antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil. - Drugs & Drug Targets
-
Drug Target Type Ibritumomab tiuxetan B-lymphocyte antigen CD20 target Tositumomab B-lymphocyte antigen CD20 target Tositumomab Low affinity immunoglobulin gamma Fc region receptor II-b target Ofatumumab B-lymphocyte antigen CD20 target Obinutuzumab B-lymphocyte antigen CD20 target